[1]
H. Yaribeygi, M. Maleki, T. Jamialahamdi, S. A. Moallem, and A. Sahebkar, “Hepatic benefits of sodium-glucose cotransporter 2 inhibitors in liver disorders”, EXCLI J., vol. 22, pp. 403–414, Apr. 2023.